| Serge Weinberg |
Serge Weinberg is a French businessperson who founded Institut du Cerveau et de la Moelle Épinière and Weinberg Capital Partners SAS and who has been at the helm of 19 different companies. Presently, he holds the position of Chairman for Maremma SASU, Chairman for Financière Piasa SAS, Chairman at Piasa Holding SAS, Chairman of Sanofi and President at Weinberg Capital Partners SAS. Mr. Weinberg is also on the board of Piasa SA (former Chairman) and AFEPT and Manager at Alret, Manager at Maremma and Member of Council on Foreign Relations, Inc.
In his past career Serge Weinberg was Chairman-Supervisory Board of Tess SAS, Chairman & Chief Executive Officer for Rexel SA, Chairman for Accor SA, Chairman at CORUM Vermögensverwaltung AG, Chairman-Supervisory Board of Financière Tess SAS, Chairman-Supervisory Board of Financière Climater SAS, Director at VL Holding (France), Chief Executive Officer & Director at Pallas Finance, Chairman-Management Board at Kering SA, President-CFAO at Pinault SARL, Manager of Adoval, Chairman at Montres CORUM Sà rl, Chairman & Chief Executive Officer at Havas Tourisme, President for Compagnie Française de L'Afrique Occidentale SA and Deputy General Manager-Finance at France 3 SA.
Mr. Weinberg received a graduate degree from Institut d'Études Politiques d'Aix-en-Provence and an undergraduate degree from Ecole Nationale d'Administration. |
| Bernard Charlès |
Bernard Charlès is a French businessperson who has been at the head of 15 different companies and occupies the position of Vice Chairman & Chief Executive Officer at Dassault Systèmes SA and Chairman of Dassault Systemes Geovia, Inc., Chairman for Centric Software, Inc., Chairman & Chief Executive Officer at Exa Corp., Chairman for Dassault Systèmes Corp., Chairman of Dassault Systemes Simulia Corp. and Chief Executive Officer & Vice Chairman at Exalead SA (which are all subsidiaries of Dassault Systèmes SA) and Chairman at Dassault Systemes Solidworks Corp. Dr. Charlès is also on the board of Sanofi and Member of National Academy of Engineering.
In his past career he was Chairman for Dassault Systèmes Canada Software, Inc., Chairman-Supervisory Board of Dassault Systemes 3DExcite GmbH, Chairman of IQMS, Chairman for Dassault Systemes Biovia Corp., Chairman at Dassault Systemes Enovia Corp., Chairman of Delmia Corp., President of Dassault Systèmes Canada, Inc. and Member of Académie des Technologies.
He received an undergraduate degree from École normale supérieure de Cachan. |
| John C. Reed |
Founder of Idun Pharmaceuticals, Inc. and Apoptos, Inc., John C. Reed presently is EVP & Global Head-Research & Development at Sanofi and President & Director at Synthorx, Inc. (a subsidiary of Sanofi). He is also on the board of BIOCOM.
Dr. Reed previously occupied the position of Head-Roche Pharma Research & Early Development at Roche Holding AG, President, Chief Executive Officer & Professor at Sanford Burnham Prebys Medical Discovery Institute, Associate Member at the University of California San Diego, Assistant Director at the University of Pennsylvania and Associate Member at Whitaker Institute of Biomedical Engineering.
John C. Reed received an undergraduate degree from the University of Virginia and a doctorate from Perelman School of Medicine. |
| Patrick Kron |
Patrick Kron is a French businessperson who founded Pkc&I SAS and who has been at the helm of 12 different companies. Mr. Kron is Chairman at this company and Chairman at Imerys SA. He is also on the board of 6 other companies.
In the past he was Chairman & Chief Executive Officer for Alstom SA Chairman & Chief Executive Officer at Alstom Transport SA, Chairman for ALSTOM Resources Management SAS, Chief Executive Officer & Director at Alstom Asia Pacific Sdn. Bhd. and Managing Director & Director at Alstom Asia Pte Ltd. (which are all subsidiaries of Alstom SA), Chairman at Mersen SA and Chairman & Chief Executive Officer for Carbone Lorraine Applications Electriques (a subsidiary of Mersen SA), Chief Executive Officer at Vivendi SA, Chairman & Chief Executive Officer at Pechiney Electrométallurgie SA, Chief Executive Officer of Imerys SA, Chief Operating Officer at American National Can Corp and Manager-Food & Health Care Packaging Sector at Pechiney SA.
He received an undergraduate degree from Ecole Polytechnique and an undergraduate degree from École Nationale Supérieure des Mines de Paris. |
| Alan J. Main |
Alan J. Main occupies the position of Executive Vice President-CMC & Supply Operations at Lexicon Pharmaceuticals, Inc.
Dr. Main previously held the position of President & Chief Executive Officer for Coelacanth Corp and Senior Vice President-US Research at Novartis Pharmaceuticals Corp.
Dr. Main received an undergraduate degree from the University of Aberdeen and a doctorate from The University of Liverpool. |
| Muzammil M. Mansuri |
Presently, Muzammil M. Mansuri holds the position of Executive Chairman of Adaptive Therapeutics, Inc. Dr. Mansuri is also Executive VP-Strategy & Business Development at Sanofi.
In his past career Dr. Mansuri occupied the position of General Partner at Flagship Pioneering, SVP-Research & Development Strategy at Gilead Sciences, Inc. and Chairman & Chief Executive Officer of Gilead Connecticut, Inc. (a subsidiary of Gilead Sciences, Inc.), Director-Central Chemistry at Bristol-Myers Squibb Co., Senior Advisor at JSB-Partners LP, Chief Operating Officer & Executive Vice President of GPC Biotech, Inc., President & Chief Executive Officer at BIKAM Pharmaceuticals, Inc. and Research Scientist at Shell Research Ltd.
Muzammil M. Mansuri received a doctorate and an undergraduate degree from University College London, a doctorate from the University of California, Los Angeles and a doctorate from Columbia University. |
| Lise Kingo |
Currently, Lise Kingo is Chairman of Danish Council On Corporate Social Responsibility. Ms. Kingo is also on the board of Sanofi and Learning Disabilities Association of Minnesota and Professor at Vrije Universiteit Amsterdam.
In her past career Ms. Kingo held the position of Chairman at Steno Diabetes Center A, Chief of Staff & Executive Vice President at Novo Nordisk An and Chief Executive Officer & Executive Director at United Nations Global Compact.
Ms. Kingo received an undergraduate degree from the University of Aarhus, an undergraduate degree from Copenhagen Business School and a graduate degree from the University of Bath. |
| Carole Piwnica |
Ms. Carole Piwnica is Member-Supervisory Board at Rothschild & Co. SCA, Chairman at i2O Water Ltd., Independent Director at Sanofi, Independent Director at Eutelsat Communications SA, Independent Director at Amyris, Inc., a Director at Select Music & Video Distribution Ltd., a Managing Director at Naxos UK Ltd., a Managing Director at NAXOS Capital Managers SARL, a Member at New York State Bar Association and a Member at Paris Bar Association. She is on the Board of Directors at Rothschild & Co. SCA, Sanofi, Elevance Renewable Sciences, Inc., Eutelsat Communications SA, Amyris, Inc., Big Red, Inc., Select Music & Video Distribution Ltd. and RecyCoal Ltd.
Ms. Piwnica was previously employed as Independent Director by Louis Delhaize SA, Independent Non-Executive Director by Aviva Plc, Non-Executive Director by SPADEL SA, a Director & Vice Chairman-Governmental Affairs by Tate & Lyle Plc, and Chairman by Amylum. She also served on the board at BioAmber, Inc., Confederation of the Food & Drink Industries of Eu, Alfred C. Toepfer International GmbH, Charal SAS, Cacao Barry, and TargeGen, Inc.
Ms. Piwnica received her graduate degree from Université Libre de Bruxelles and a graduate degree from New York University. |
| Gilles Schnepp |
Gilles Schnepp is a French businessperson who has been at the helm of 26 different companies. He holds the position of Chairman for Tenby Electrical Accessories Ltd., Chairman of Compagnie Franco Européenne d'Electricité, Chairman at Préfatech, Chairman at Appareillage Electrique Chessy, Chairman at Pammelec SAS, Chairman for Fidelec, Chairman at Legrand China Holding, President for Fédération des Industries Electriques, Electroniques, Chairman at TCL Low Voltage Electrical (Wuxi) Co. Ltd., Chairman for Alpes Technologies SA, Chairman at Legrand (S) Pte Ltd., Chairman & Co-Chief Executive Officer at Legrand Electric Ltd., Chairman for S2S SAS, Chairman at Distrasa SA, Chairman for URA SAS, Chairman for Groupe Arnould SAS, Chairman at Sarlam, Chairman for Simapel, Chairman of BTICINO Philippines, Inc. and Chairman for LEGRAND Magyarország Villamossági Rendszerek Zrt. Mr. Schnepp is also Manager at Legrand SNC and Manager for Planet-Wattohm SNC and on the board of 23 other companies.
In his past career he occupied the position of Chairman for INTERVOX Systèmes SA, Chairman of BTicino SpA, Chairman-Supervisory Board for Chateaudun Développement III SAS, Chairman of ICM Group SA, Chairman & Chief Executive Officer for Legrand France SA, Director & Manager at Legrand SLV doo and Vice President of Merrill Lynch Finance SA.
He received an undergraduate degree from École des Hautes Études Commerciales de Paris. |
| Melanie Georgina Lee |
Founder of Think10 and NightstaRx Ltd., Melanie Georgina Lee is on the board of Sanofi and UK DRI Ltd. and Chief Executive Officer at Lifearc.
She previously held the position of Chairman at Cancer Research Technology Ltd., Chief Executive Officer of NightstaRx Ltd., Executive Vice President-Research & Development at UCB Pharma, Inc., Director-Research & Development at Celltech Group Ltd., Chief Scientific Officer at BTG Plc, President-New Medicines at UCB Celltech, Principal at GlaxoSmithKline Pharmaceuticals SA (Belgium), Research Unit Head-Receptor Systems at GlaxoWellcome and Director at Think10.
She received an undergraduate degree from York University and a doctorate from The National Institute For Medical Research. |
| Laurent Attal |
Laurent Attal occupies the position of Vice President & GM-Research & Innovation at L'Oréal SA. Dr. Attal is also on the board of Sanofi and L'Oréal Corporate Foundation.
In the past Dr. Attal held the position of Chief Executive Officer of Vichy, President & Chief Executive Officer of L'Oréal USA, Inc. and Manager at Galderma SA.
Laurent Attal received an MBA from INSEAD. |
| Claudie Haigneré |
Claudie Haigneré is Member of Academie de l'air et de l'espace, Member of Académie des Sciences et Technologies, Member of Académie Des Sciences D'Outre-Mer and Member of Academie des Sports and on the board of 6 other companies.
In her past career she held the position of Chairman for Universcience.fr, Chairman at La Géode, Counselor at European Space Agency (France), Member of International Academy of Astronautics and Member of Académie des Technologies. |
| Emmanuel Andre Marie Babeau |
Emmanuel Andre Marie Babeau is Chief Financial Officer at Philip Morris International, Inc. Mr. Babeau is also Managing Partner at Sci Getij and on the board of 12 other companies.
In the past Mr. Babeau was Deputy Chief Executive Officer-Finance & Legal at Schneider Electric SE Chairman & Member-Management Board at Schneider Electric Services International, Chief Financial Officer at Schneider Electric Ltd. and Member-Management Board at Schneider SA (which are all subsidiaries of Schneider Electric SE) and Deputy Chief Executive Officer at Pernod Ricard SA.
He received an undergraduate degree from ESCP Europe Campus Paris. |
| Rachel Duan |
Currently, Rachel Duan occupies the position of President & Chief Executive Officer of General Electric (China) Co., Ltd. She is also on the board of AXA SA and Sanofi.
Ms. Duan previously occupied the position of Senior Vice President of General Electric Co. President & Chief Executive Officer at GE Healthcare China and Commercial Director at GE Plastics China Ltd. (both are subsidiaries of General Electric Co.).
Rachel Duan received an MBA from the University of Wisconsin and an undergraduate degree from Shanghai International Studies University. |
| Karen Linehan |
Presently, Karen Linehan occupies the position of Executive VP-Legal Affairs & General Counsel at Sanofi.
She received a graduate degree and an undergraduate degree from Georgetown University. |
| Philippe Luscan |
Philippe Luscan is Executive Vice President-Global Industrial Affairs at Sanofi.
In the past Mr. Luscan held the position of Production Manager at Danone SA.
He received an undergraduate degree from Ecole Polytechnique and an undergraduate degree from École Nationale Supérieure des Mines de Paris. |
| Olivier Antoine M. Charmeil |
Olivier Antoine M. Charmeil is EVP-General Medicines & Emerging Markets at Sanofi.
In the past Mr. Charmeil occupied the position of Chairman-Management Board at Zentiva Group AS, Chairman & Chief Executive Officer at Sanofi-Synthélabo SA and Head-Business Development of Sanofi Pharma.
He received an undergraduate degree from Sciences Po and an undergraduate degree from École des Hautes Études Commerciales de Paris. |
| Fabienne Lecorvaisier |
Presently, Fabienne Lecorvaisier is Chief Financial Officer & Executive Vice President of Air Liquide SA and Chairman & Chief Executive Officer at Air Liquide Finance SA and Executive Vice President of Air Liquide International Corp. (both are subsidiaries of Air Liquide SA). She is also Executive Vice President at Air Liquide International Corp. and on the board of 8 other companies.
Fabienne Lecorvaisier previously occupied the position of Vice President-Operations & Finance at Air Liquide Italia SpA, Chief Financial Officer of Essilor Group Canada, Inc., Director-Finance & Information Systems at Essilor of America, Inc., Assistant General Manager at Taittinger SAS and Assistant General Manager at Banque du Louvre.
Ms. Lecorvaisier received an undergraduate degree from Ecole Nationale des Ponts et Chaussées. |
| Thomas C. Südhof |
Founder of Reata Pharmaceuticals, Inc., Neucyte, Inc. and Circuit Therapeutics, Inc., Thomas C. Südhof is an entrepreneur is on the board of Sanofi and Abide Therapeutics, Inc. and Professor at Stanford University School of Medicine.
He previously was Assistant Professor at The University of Texas Southwestern Medical Center.
He received a doctorate from RWTH Aachen University and an undergraduate degree from the University of Gottingen. |
| Jean-Baptiste Chasseloup de Chatillon |
Jean-Baptiste Chasseloup de Chatillon is a French businessperson who has been the head of 5 different companies and currently is Chief Financial Officer & Executive Vice President at Sanofi, Chairman at Mister-Auto SAS and Vice Chairman & Chief Executive Officer at PSA International SA. He is also Chief Financial & Information Officer at Fondation PSA Peugeot Citroën, Member of City on the Move Institute and Associate Manager at Peugeot Media Production and on the board of 11 other companies.
Jean-Baptiste Chasseloup de Chatillon previously occupied the position of Chairman of Asm Auto Sud Marche SAS and CFO & Executive VP-Strategic Development at Peugeot SA Director at Banque PSA Finance SA, Chairman-Supervisory Board for Peugeot Finance International NV and Managing Director at Citroën BELUX SA (which are all subsidiaries of Peugeot SA).
He received an undergraduate degree from Université Paris Dauphine and an undergraduate degree from the University of Lancaster. |
| Dominique Carouge |
Presently, Dominique Carouge is Executive VP & Head-Business Transformation at Sanofi.
In his past career he was Chief Financial Officer for Hoechst Marion Roussel Australia Pty Ltd.
He received an undergraduate degree from Reims Management School. |
| Dietmar P. Berger |
Presently, Dietmar P. Berger holds the position of Chief Medical Officer & Global Head-Development at Sanofi.
Dr. Berger previously occupied the position of Global Head-Research & Development at Atara Biotherapeutics, Inc., Head-Clinical Research Centre at Universitätsklinikum Freiburg, Vice President-Clinical Hematology & Oncology at Genentech, Inc. and Head-Clinical Research Centre at The Scripps Research Institute.
He received a graduate degree and a doctorate from the University of Freiburg. |
| David G. Loew |
David G. Loew is Global Head-Vaccines at Sanofi.
He previously occupied the position of Global Head-Product Strategy at Genentech, Inc. |
| Caroline Luscombe |
Currently, Caroline Luscombe holds the position of Executive Vice President-Human Resources for Sanofi.
She previously occupied the position of Head-Organization & Human Resources at LafargeHolcim Ltd., Executive Vice President-Human Resources at Amersham Plc and Head-Human Resources for Syngenta AG.
She received an undergraduate degree from University College London. |
| Paul Hudson |
Paul Hudson is a businessperson who has been the head of 5 different companies. Currently, he is Chief Executive Officer & Director at Sanofi and Chairman of Novartis Pharma KK.
Mr. Hudson previously occupied the position of Member-Executive Committee at Novartis AG and Chief Executive Officer at Novartis Pharmaceuticals Corp. (a subsidiary of Novartis AG) and President-AstraZeneca US & EVP-North America at AstraZeneca Plc President & Director at AstraZeneca KK and President at AstraZéneca Farmacéutica Spain SA (both are subsidiaries of AstraZeneca Plc).
Paul Hudson received an undergraduate degree from Manchester Metropolitan University of. |
| Ameet Nathwani |
Currently, Ameet Nathwani holds the position of Chief Medical & Digital Officer at Sanofi.
In the past he occupied the position of Global Head-Medical Affairs at Novartis Pharma AG and Head-Critical Care at Novartis Pharma AG. |
| Arnaud Robert |
Arnaud Robert is Chief Digital Officer of Viking Cruises Ltd. and Chief Digital Officer of Sanofi.
Dr. Robert previously occupied the position of Senior Vice President-Technology Strategy at Shaw Communications, Inc. |
| Diane D. Souza |
Diane D. Souza is on the board of Amica Mutual Insurance Co., Sanofi, Farm Credit East, ACA and DBP Services of New York IPA, Inc.
In the past he was Chief Executive Officer-Specialty Benefits at UnitedHealth Group, Inc. Chief Executive Officer for UnitedHealthcare Specialty Benefits LLC and COO-OptumHealth Specialty Benefits at OptumHealth, Inc. (both are subsidiaries of UnitedHealth Group, Inc.), Accountant of Pricewaterhouse LLP and CFO-Guaranteed Products Business at Aetna, Inc.
Mr. Souza received an undergraduate degree from the University of Massachusetts. |
| Bill Sibold |
Bill Sibold is on the board of Biotechnology Innovation Organization and Executive Vice President-Sanofi Genzyme at Sanofi. |
| Marion Palme |
Marion Palme is on the board of Sanofi and Member of Industriegewerkschaft Bergbau Chemie Energie.
In her past career she held the position of Member of European Works Council.
She received an undergraduate degree from Provadis School of International Management & Technology. |
| Christian Senectaire |
Christian Senectaire is on the board of Sanofi. |
| Nestle Frank |
Currently, Nestle Frank occupies the position of Global Head-Immunology Therapeutic Research Area at Sanofi. |
| Christophe Babule |
Currently, Christophe Babule holds the position of Chief Financial Officer & Executive Vice President at L'Oréal SA. He is also on the board of Sanofi and L'Oréal USA, Inc.
He previously occupied the position of Director-Finance & Administration at L'Oréal México SA de CV.
Mr. Babule received an undergraduate degree from École des Hautes Études Commerciales de Paris. |
| Alan Main |
Alan Main is Executive Vice President-Consumer Health Care at Sanofi.
Mr. Main previously held the position of Marketing Manager at Roche Enterprises Ltd. and Chairman-Marketing Council at Bayer HealthCare AG.
He received an undergraduate degree from the University of Greenwich. |
| Claire Terrazas |
Claire Terrazas is Vice President-Corporate Legal Affairs at Sanofi. |
| Arnaud Delépine |
Arnaud Delépine holds the position of Investor Relations Officer at Sanofi. |
